Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea

Abstract Background Chloroquine treatment for Plasmodium falciparum has been discontinued in almost all endemic regions due to the spread of resistant isolates. Reversal of chloroquine susceptibility after chloroquine discontinuation has been reported in dozens of endemic regions. However, this phen...

Full description

Bibliographic Details
Main Authors: Makoto Sekihara, Shin-Ichiro Tachibana, Masato Yamauchi, Shoki Yatsushiro, Steven Tiwara, Naoyuki Fukuda, Mie Ikeda, Toshiyuki Mori, Makoto Hirai, Francis Hombhanje, Toshihiro Mita
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-018-2585-x
_version_ 1819049676393938944
author Makoto Sekihara
Shin-Ichiro Tachibana
Masato Yamauchi
Shoki Yatsushiro
Steven Tiwara
Naoyuki Fukuda
Mie Ikeda
Toshiyuki Mori
Makoto Hirai
Francis Hombhanje
Toshihiro Mita
author_facet Makoto Sekihara
Shin-Ichiro Tachibana
Masato Yamauchi
Shoki Yatsushiro
Steven Tiwara
Naoyuki Fukuda
Mie Ikeda
Toshiyuki Mori
Makoto Hirai
Francis Hombhanje
Toshihiro Mita
author_sort Makoto Sekihara
collection DOAJ
description Abstract Background Chloroquine treatment for Plasmodium falciparum has been discontinued in almost all endemic regions due to the spread of resistant isolates. Reversal of chloroquine susceptibility after chloroquine discontinuation has been reported in dozens of endemic regions. However, this phenomenon has been mostly observed in Africa and is not well documented in other malaria endemic regions. To investigate this, an ex vivo study on susceptibility to chloroquine and lumefantrine was conducted during 2016–2018 in Wewak, Papua New Guinea where chloroquine had been removed from the official malaria treatment regimen in 2010. Genotyping of pfcrt and pfmdr1 was also performed. Results In total, 368 patients were enrolled in this study. Average IC50 values for chloroquine were 106.6, 80.5, and 87.6 nM in 2016, 2017, and 2018, respectively. These values were not significantly changed from those obtained in 2002/2003 (108 nM). The majority of parasites harboured a pfcrt K76T the mutation responsible for chloroquine resistance. However, a significant upward trend was observed in the frequency of the K76 (wild) allele from 2.3% in 2016 to 11.7% in 2018 (P = 0.008; Cochran–Armitage trend test). Conclusions Eight years of chloroquine withdrawal has not induced a significant recovery of susceptibility in Papua New Guinea. However, an increasing tendency of parasites harbouring chloroquine-susceptible K76 suggests a possibility of resurgence of chloroquine susceptibility in the future.
first_indexed 2024-12-21T11:35:56Z
format Article
id doaj.art-0f22cbd8a86445a68061ed4aa03a3ed4
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-21T11:35:56Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-0f22cbd8a86445a68061ed4aa03a3ed42022-12-21T19:05:27ZengBMCMalaria Journal1475-28752018-11-0117111010.1186/s12936-018-2585-xLack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New GuineaMakoto Sekihara0Shin-Ichiro Tachibana1Masato Yamauchi2Shoki Yatsushiro3Steven Tiwara4Naoyuki Fukuda5Mie Ikeda6Toshiyuki Mori7Makoto Hirai8Francis Hombhanje9Toshihiro Mita10Department of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineHealth Technology Research Center, National Institute of Advanced Industrial Science and Technology (AIST)Wewak General HospitalDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineCentre for Health Research & Diagnostics, Divine Word UniversityDepartment of Tropical Medicine and Parasitology, Juntendo University, Faculty of MedicineAbstract Background Chloroquine treatment for Plasmodium falciparum has been discontinued in almost all endemic regions due to the spread of resistant isolates. Reversal of chloroquine susceptibility after chloroquine discontinuation has been reported in dozens of endemic regions. However, this phenomenon has been mostly observed in Africa and is not well documented in other malaria endemic regions. To investigate this, an ex vivo study on susceptibility to chloroquine and lumefantrine was conducted during 2016–2018 in Wewak, Papua New Guinea where chloroquine had been removed from the official malaria treatment regimen in 2010. Genotyping of pfcrt and pfmdr1 was also performed. Results In total, 368 patients were enrolled in this study. Average IC50 values for chloroquine were 106.6, 80.5, and 87.6 nM in 2016, 2017, and 2018, respectively. These values were not significantly changed from those obtained in 2002/2003 (108 nM). The majority of parasites harboured a pfcrt K76T the mutation responsible for chloroquine resistance. However, a significant upward trend was observed in the frequency of the K76 (wild) allele from 2.3% in 2016 to 11.7% in 2018 (P = 0.008; Cochran–Armitage trend test). Conclusions Eight years of chloroquine withdrawal has not induced a significant recovery of susceptibility in Papua New Guinea. However, an increasing tendency of parasites harbouring chloroquine-susceptible K76 suggests a possibility of resurgence of chloroquine susceptibility in the future.http://link.springer.com/article/10.1186/s12936-018-2585-xPlasmodium falciparumChloroquineResistanceRecoverypfcrtFitness
spellingShingle Makoto Sekihara
Shin-Ichiro Tachibana
Masato Yamauchi
Shoki Yatsushiro
Steven Tiwara
Naoyuki Fukuda
Mie Ikeda
Toshiyuki Mori
Makoto Hirai
Francis Hombhanje
Toshihiro Mita
Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
Malaria Journal
Plasmodium falciparum
Chloroquine
Resistance
Recovery
pfcrt
Fitness
title Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
title_full Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
title_fullStr Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
title_full_unstemmed Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
title_short Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea
title_sort lack of significant recovery of chloroquine sensitivity in plasmodium falciparum parasites following discontinuance of chloroquine use in papua new guinea
topic Plasmodium falciparum
Chloroquine
Resistance
Recovery
pfcrt
Fitness
url http://link.springer.com/article/10.1186/s12936-018-2585-x
work_keys_str_mv AT makotosekihara lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT shinichirotachibana lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT masatoyamauchi lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT shokiyatsushiro lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT steventiwara lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT naoyukifukuda lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT mieikeda lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT toshiyukimori lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT makotohirai lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT francishombhanje lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea
AT toshihiromita lackofsignificantrecoveryofchloroquinesensitivityinplasmodiumfalciparumparasitesfollowingdiscontinuanceofchloroquineuseinpapuanewguinea